Expertise in
2
conditions

Pramila Krishnamurthy

Denmark Hill, 
London, ENG, GB 
Expertise in
2
conditions
Denmark Hill, 
London, ENG, GB 

Overview

Pramila Krishnamurthy practices practicing medicine in London, United Kingdom.

Krishnamurthy is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Hepatic Venoocclusive Disease with Immunodeficiency, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 1 clinical trial.

Locations

Denmark Hill, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse Who Are Eligible for High Dose Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation (ASCT)
Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse Who Are Eligible for High Dose Treatment Followed by Autologous Peripheral Blood Stem Cell Transplantation (ASCT)
Enrollment Status: Unknown
Publish Date: March 13, 2018
Intervention Type: Drug, Other
Study Drugs: DHAP, Brentuximab Vedotin
Study Phase: Phase 1

33 Total Publications

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.
Journal: Leukemia
Published: May 24, 2025

Frequently Asked Questions about Pramila Krishnamurthy

Is Pramila Krishnamurthy a top-rated expert for Myelodysplastic Syndrome (MDS)?

MediFind is an objective health platform that identifies experts based on real-world data. Pramila Krishnamurthy is classified as an Advanced expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pramila Krishnamurthy participate in research or clinical trials?

Yes. Pramila Krishnamurthy has published 33 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Pramila Krishnamurthy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Krishnamurthy's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile